19.12.2012 Views

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

The relative potency <strong>of</strong> each volatile anesthetic agent is measured in terms <strong>of</strong> the minimum alveolar<br />

concentration (MAC) <strong>of</strong> an inhaled anesthetic agent at which 50% <strong>of</strong> patients do not have skeletal<br />

muscle movement in response to surgical incision or another noxious stimulus. The patient's age<br />

appears to influence the MAC <strong>of</strong> a given volatile anesthetic, and MAC is higher in infants than in any<br />

other age group. MAC may be 15-25% lower in neonates than in infants and is even lower in premature<br />

neonates. Volatile anesthetic agents are potent myocardial depressants and vasodilators.<br />

Consequently, systolic blood pressure and mean arterial blood pressure may decrease when these<br />

agents are administered. In some neonates, other analgesic agents may be used to decrease volatile<br />

anesthetic agent requirements intraoperatively, thereby avoiding some <strong>of</strong> the hemodynamic changes<br />

that may occur with volatile anesthetic administration.<br />

In fact, surgical anesthesia can be accomplished without the use <strong>of</strong> any volatile anesthetic agents.<br />

Narcotics are not complete anesthetic agents; they do not provide muscle relaxation or amnesia, which<br />

are essential functions <strong>of</strong> complete anesthetics. However, they are potent analgesic medications.<br />

Administration <strong>of</strong> these agents intraoperatively may be associated with less <strong>of</strong> a decrease in blood<br />

pressure in neonates than might occur with volatile anesthetic administration. Furthermore, narcotics<br />

are useful adjuncts to anesthetics based on volatile agents because they can reduce the volatile agent<br />

requirement, thereby reducing any hemodynamic lability. Narcotic-based anesthetics are commonly<br />

used during cardiovascular procedures in neonates.<br />

Physicians should note that the pharmacokinetics <strong>of</strong> narcotics administered to neonates differs from<br />

that <strong>of</strong> older infants, children, and adolescents. Neonates have a lower clearance, greater volume <strong>of</strong><br />

distribution, longer elimination half-life, and higher plasma concentration after narcotic boluses than<br />

older patients. Consequently, the postoperative disposition <strong>of</strong> neonates may be affected when narcotics<br />

are used intraoperatively. Narcotics commonly used for intraoperative analgesia in neonates include<br />

morphine, fentanyl, sufentanil, and remifentanil.<br />

Ketamine, a phencyclidine derivative, produces amnesia and intense analgesia. This drug affects<br />

opioid receptors and N-methyl-D-aspartate (NDMA) receptors, as well as voltage-sensitive calcium ion<br />

channels as it induces its analgesic effects. Ketamine actually stimulates the cardiovascular system<br />

and thus is frequently associated with increases in both systolic and mean arterial blood pressure, as<br />

well as heart rate, when administered intraoperatively. While ketamine may not be associated with<br />

increased blood pressure in preterm neonates, it is certainly associated with smaller decreases in mean<br />

arterial pressure and systolic blood pressure than the other analgesic medications commonly used<br />

intraoperatively. Beneficial effects <strong>of</strong> ketamine include production <strong>of</strong> bronchodilation and less<br />

depression <strong>of</strong> ventilation. Adverse effects that may occur in neonates include increased salivary and<br />

tracheobronchial secretion production, cerebral vasodilation, and apnea in neonates with increased<br />

intracranial pressure.<br />

POSTOPERATIVE PAIN ASSESSMENT IN NEONATES Section 6 <strong>of</strong> 10<br />

One factor that has contributed to inadequate pain management in neonates has been the pervasive<br />

belief that neonates do not feel pain. This misconception has been perpetuated, at least in part, by the<br />

conspicuous absence <strong>of</strong> adequate tools to assess pain levels in this patient population. To a large<br />

extent, pain assessment in older patients relies upon the patient's ability to report pain level in some<br />

form to the caregiver. When patients cannot express pain verbally, pain assessment depends more on<br />

evaluations by the caregiver. Even when pain is evident, quantifying the pain level is not easy. An<br />

effective pain assessment tool must be able to objectively quantify the pain level <strong>of</strong> the patient so that<br />

the healthcare provider can accurately measure the effectiveness <strong>of</strong> interventions designed to alleviate<br />

unnecessary suffering. Although no perfect tool exists yet for assessing pain in neonates, infants, and<br />

preverbal children, several very useful tools are available.<br />

The Children's Hospital <strong>of</strong> Eastern Ontario Pain Scale (CHEOPS) was one <strong>of</strong> the first observational<br />

pain scales. This tool includes the categories <strong>of</strong> (1) cry, (2) facial expression, (3) verbal response, (4)<br />

torso position, (5) leg activity, and (6) arm movement in relationship to the surgical wound. In general,

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!